首页> 外文期刊>Journal of Kathmandu Medical College >Prophylactic Altropine administration should be considered during laparoscopic surgery
【24h】

Prophylactic Altropine administration should be considered during laparoscopic surgery

机译:腹腔镜手术中应考虑预防性阿托品给药

获取原文
           

摘要

Background: Routine use of vagotonic drugs during general anaesthesia with mechanical ventilation and carboperitoneum creation during laparoscopic surgery may lead to severe bradycardia and even asystole, which can be countered by prophylactic use of Atropine sulphate. Objective: To study whether Atropine sulphate administered one minute after endotracheal intubation will be effective in preventing bradycardia induced by vagotonic anaesthetics and carboperitoneum during laparoscopic surgery. Methods: Ninety two patients of American Society of Anaesthesiologist Physical Status I were included in the study. These patients were randomly divided into two groups (Control group and Atropine group) of 46 each by envelope method. Control group received one mL of saline and Atropine group received 0.6 mg (one mL) Atropine one minute after endotracheal intubation. Heart rate, systolic, diastolic and mean arterial pressures were monitored before intubation; one, three and fi ve minutes after intubation; fi ve, 15 and 30 minutes after carboperitoneum creation and before and after extubation. Atropine 0.6 mg was given intravenously if any of patients developed heart rate less than 50 beats per minute. Results: Demographic characteristics were similar in both groups. Thirty percent (14 out of 46) of patients in control group developed bradycardia immediately after carboperitoneum creation and no patients developed bradycardia in atropine group. Haemodynamic parameters after intubation, during intraoperative period and after extubation were similar in both groups. Conclusion: Vagolytic drug (Atropine sulphate) should be considered if vagotonic anaesthetic drugs are used along with carboperitoneum creation during laparoscopic surgery.DOI: http://dx.doi.org/10.3126/jkmc.v2i2.10622Journal of Kathmandu Medical College, Vol. 2, No. 2, Issue 4, Apr.-Jun., 2013, Page : 45-50
机译:背景:在全身麻醉期间常规使用迷走神经性药物,并在腹腔镜手术期间使用机械通气和产生气腹,可能会导致严重的心动过缓,甚至发生心搏停止,这可以通过预防性使用硫酸阿托品来解决。目的:探讨气管插管后一分钟服用阿托品硫酸盐是否能有效预防腹腔镜手术中迷走神经麻醉药和卡培他汀引起的心动过缓。方法:本研究纳入了92例美国麻醉医师学会物理状态I患者。通过包膜法将这些患者随机分为两组(对照组和阿托品组),每组46例。气管内插管后1分钟,对照组接受1 mL盐水,阿托品组接受0.6 mg(1 mL)阿托品。插管前监测心率,收缩压,舒张压和平均动脉压。插管后一,三,五分钟;在开腹后十五分钟和三十分钟内,拔管前后。如果任何患者的心率低于每分钟50次,则静脉注射阿托品0.6 mg。结果:两组的人口统计学特征相似。对照组中有百分之三十(46名患者中有14名)在开腹后立即出现心动过缓,阿托品组没有患者出现心动过缓。两组在插管后,术中和拔管后的血流动力学参数相似。结论:如果在腹腔镜手术中同时使用迷走神经麻醉药和产生碳腹膜炎,应考虑使用迷走神经药物(硫酸阿托品).DOI:http://dx.doi.org/10.3126/jkmc.v2i2.10622加德满都医学院学报。 2,第2期,第4期,2013年4月-6月,页面:45-50

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号